Weicheng Pharmaceuticals Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $54M

  • Investors
  • 4

Weicheng Pharmaceuticals General Information

Description

Developer of a proprietary extrahepatic drug delivery platform designed to advance targeted small nucleic acid therapies beyond hepatic tissues. The company offers specialized delivery mechanisms and preclinical pipeline innovations, enabling biotechnology developers focused on non-hepatic conditions to address critical therapeutic gaps with enhanced precision.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 1101, Building 1, Number 68 Xinqing Road, Suzhou Industrial Park
  • Suzhou Area of China Pilot Free Trade Zone
  • Suzhou, Jiangsu
  • China
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • Room 1101, Building 1, Number 68 Xinqing Road, Suzhou Industrial Park
  • Suzhou Area of China Pilot Free Trade Zone
  • Suzhou, Jiangsu
  • China

Weicheng Pharmaceuticals Timeline

2026
Date FoundedFinancing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Weicheng Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 09-Apr-2026 $54M Completed Generating Revenue
1. Seed Round 19-Aug-2025 Completed Startup
To view Weicheng Pharmaceuticals’s complete valuation and funding history, request access »

Weicheng Pharmaceuticals Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Highlight Capital Venture Capital Minority
TF Capital Venture Capital Minority
Apricot Capital (Shanghai) Venture Capital Minority
Qiming Venture Partners Venture Capital Minority
To view Weicheng Pharmaceuticals’s complete investors history, request access »

Weicheng Pharmaceuticals FAQs

  • When was Weicheng Pharmaceuticals founded?

    Weicheng Pharmaceuticals was founded in 2025.

  • Where is Weicheng Pharmaceuticals headquartered?

    Weicheng Pharmaceuticals is headquartered in Suzhou, China.

  • What industry is Weicheng Pharmaceuticals in?

    Weicheng Pharmaceuticals’s primary industry is Drug Delivery.

  • Is Weicheng Pharmaceuticals a private or public company?

    Weicheng Pharmaceuticals is a Private company.

  • What is Weicheng Pharmaceuticals’s current revenue?

    The current revenue for Weicheng Pharmaceuticals is .

  • How much funding has Weicheng Pharmaceuticals raised over time?

    Weicheng Pharmaceuticals has raised $64M.

  • Who are Weicheng Pharmaceuticals’s investors?

    Highlight Capital, TF Capital, Apricot Capital (Shanghai), and Qiming Venture Partners have invested in Weicheng Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process